- Home
- LICN vs TXMD Comparison
LICN vs TXMD Comparison
Compare LICN & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICN
- TXMD
- Stock Information
- Founded
- LICN 2004
- TXMD 2008
- Country
- LICN China
- TXMD United States
- Employees
- LICN 452
- TXMD N/A
- Industry
- LICN
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- LICN
- TXMD Health Care
- Exchange
- LICN Nasdaq
- TXMD Nasdaq
- Market Cap
- LICN 3.0M
- TXMD 12.8M
- IPO Year
- LICN 2023
- TXMD N/A
- Fundamental
- Price
- LICN $4.13
- TXMD $1.13
- Analyst Decision
- LICN
- TXMD
- Analyst Count
- LICN 0
- TXMD 0
- Target Price
- LICN N/A
- TXMD N/A
- AVG Volume (30 Days)
- LICN 71.1K
- TXMD 60.3K
- Earning Date
- LICN 01-01-0001
- TXMD 08-11-2025
- Dividend Yield
- LICN N/A
- TXMD N/A
- EPS Growth
- LICN N/A
- TXMD N/A
- EPS
- LICN N/A
- TXMD N/A
- Revenue
- LICN $41,477,000.00
- TXMD $1,841,000.00
- Revenue This Year
- LICN N/A
- TXMD $427.09
- Revenue Next Year
- LICN N/A
- TXMD N/A
- P/E Ratio
- LICN N/A
- TXMD N/A
- Revenue Growth
- LICN 4.32
- TXMD 53.55
- 52 Week Low
- LICN $2.60
- TXMD $0.70
- 52 Week High
- LICN $488.00
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- LICN 45.47
- TXMD 44.02
- Support Level
- LICN $3.80
- TXMD $1.07
- Resistance Level
- LICN $4.38
- TXMD $1.21
- Average True Range (ATR)
- LICN 0.26
- TXMD 0.09
- MACD
- LICN -0.01
- TXMD 0.00
- Stochastic Oscillator
- LICN 53.75
- TXMD 54.68
About LICN Lichen China Limited
Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.